RT-45

14th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 2000

Jan. 29 - Feb. 5, 2000
Marilleva, Trento, Italy

RT-45

Congenital junctional ectopic tachycardia: clinical features, treatment and follow-up

Benito Musto, Berardo Sarubbi*, Valentino Ducceschi*, Antonio D’Onofrio, Ciro Cavallaro, Filippo Vecchione, Carmine Musto, Raffaele Calabro*.
*Division of Paediatric Cardiology, Second University of Naples, Monaldi Hospital, Division of Cardiology, Monaldi Hospital, Naples, Italy

Introduction

Junctional ectopic tachycardia (JET) is a rare supraventricular tachycardia presenting as a primary idiopathic arrhythmia1 or more often as a transient phenomenon immediately after surgery for heart defects2,3. Medical treatment is indicated in almost all the patients with congenital JET1,4-6. Attempts at catheter and surgical ablation are reserved only for those patients with severe congestive heart failure irresponsive to medical management1.
The purpose of our study is to examine retrospectively the clinical presentation and outcome of a cohort of 9 patients with congenital JET referred during a 20-year period time to a single Unit and all medically treated.

 

TABLE I

Patient

Sex

JET onset

HR at presentation

HR at discharge

Familiarity

Heart Failure

Decreased

Therapy
SF/EF

Follow-up

1

F

6 months

190

100

–

–

+

DG+PF

10.4 years

2

F

4 months

170

110

–

–

–

PF

3 years

3

F

6 months

240

170

+

+

+

DG+AM

8.4 years

4

F

2 months

170

120

+

–

–

AM+PF

4.1 years

5

M

5 months

170

110

–

–

–

PF

19.8 years

6

F

3 months

300

130

+

+

+

DG+AM+PF

14.7 years

7

M

2 months

270

130

+

+

+

DG+AM+PF

12.4 years

8

F

1 month

240

140

–

–

+

DG+AM+FL

8 months

9

F

6 months

300

120

+

+

+

DG+AM+FL

6.4 years

DG=digoxin; PF=propafenone; AM=amiodarone; FL=flecainide.

 

backward

forward

CARDIOnet - registered trade mark name
Copyright ฉ 1996-2000 by CARDIOnet. All rights reserved.